Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Compugen ( (CGEN) ).
Compugen, a foreign private issuer under U.S. Securities Laws and listed on the Tel Aviv Stock Exchange, has announced a revision to its filing structure, specifically updating its Form SCHEDULE 13G/A with Bristol Myers Squibb Co. This filing update might impact regulatory compliance and market activities, reflecting on the company’s ongoing legal and administrative obligations.
More about Compugen
YTD Price Performance: 34.55%
Average Trading Volume: 713,838
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $196.1M
See more insights into CGEN stock on TipRanks’ Stock Analysis page.
